Search

everythinglearnresearchcommunity

for

Search:↓

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Adding a second method to PROTACs could improve cancer treatment.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

New regenerative therapies show promise for treating hair loss.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Topical vitamin D is effective in treating vitiligo with few side effects.

Dermatologists need to understand hair products to treat hair and scalp issues better.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Some alternative treatments for hair loss might work, but more research is needed.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

No single biomarker is reliable enough for diagnosing and assessing SLE.